Chronic methamphetamine exposure induces cardiac fas-dependent and mitochondria-dependent apoptosis

Cher-Ming Liou1, Shiow-Chwen Tsai, Chia-Hua Kuo

  • 1Department of Anesthesiology, Chung Shan Medical University Hospital, Taichung, 40201, Taiwan.

Cardiovascular Toxicology
|December 6, 2013
PubMed

Insights

Chronic methamphetamine exposure triggers cardiac cell death through both Fas-dependent and mitochondria-dependent pathways. This study reveals potential mechanisms for heart damage in methamphetamine abusers.

Area of Science:

  • Cardiovascular pathology
  • Toxicology
  • Cellular biology

Background:

  • Limited data exists on chronic methamphetamine's cardiac effects.
  • Methamphetamine abuse is a public health concern with potential cardiac implications.

Purpose of the Study:

  • To investigate the impact of chronic methamphetamine exposure on cardiac apoptosis.
  • To determine if methamphetamine activates Fas-dependent (Type I) and mitochondria-dependent (Type II) apoptotic pathways in the heart.

Main Methods:

  • Male Wistar rats were administered methamphetamine (10 mg/kg) or vehicle (PBS) daily for 3 months.
  • Cardiac tissue was analyzed for structural changes, fibrosis, and apoptosis (TUNEL assay).
  • Protein levels of key apoptotic markers (caspases, TNF-α, Fas pathway proteins, Bcl-2 family proteins) were quantified.

Main Results:

  • Methamphetamine-treated rats exhibited abnormal myocardial architecture, increased fibrosis, and higher TUNEL-positive apoptotic cells.
  • Significant increases in Fas-dependent apoptosis markers (TNF-α, Fas ligand, Fas receptor, FADD, activated caspase-8, activated caspase-3) were observed.
  • Significant increases in mitochondria-dependent apoptosis markers (Bak, t-Bid, Bak/Bcl-xL ratio, activated caspase-9, activated caspase-3) were noted.

Conclusions:

  • Chronic methamphetamine exposure activates both Fas-dependent and mitochondria-dependent apoptotic pathways in the heart.
  • These activated pathways represent a potential mechanism underlying cardiac abnormalities in chronic methamphetamine users.
  • Further research is warranted to explore therapeutic strategies targeting these apoptotic pathways.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K